 | • レポートコード：MRC2012B0551 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、不妊治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。不妊治療薬の種類別市場規模（ゴナドトロピン、抗エストロゲン）、用途別市場規模（男性、女性）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、LIVZON、Ferring、MSD、Bayer Zydus Pharma、Abbott、 ・地域別グローバル市場分析 2015年-2020年 ・不妊治療薬の北米市場（アメリカ、カナダ、メキシコ） ・不妊治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・不妊治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・不妊治療薬の南米市場（ブラジル、アルゼンチン） ・不妊治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ゴナドトロピン、抗エストロゲン ・用途別分析：男性、女性 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Infertility Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Infertility Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 5793.3 million by 2025, from USD 4735.8 million in 2019.
Market segmentation
Infertility Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Infertility Drugs market has been segmented into:
Gonadotropins
Anti-Estrogens
By Application, Infertility Drugs has been segmented into:
Male
Female
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Infertility Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Infertility Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Infertility Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Infertility Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Infertility Drugs Market Share Analysis
Infertility Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Infertility Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Infertility Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Infertility Drugs are:
Merck
LIVZON
Ferring
MSD
Bayer Zydus Pharma
Abbott
Among other players domestic and global, Infertility Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Infertility Drugs Market Overview
1.1 Product Overview and Scope of Infertility Drugs
1.2 Classification of Infertility Drugs by Type
1.2.1 Global Infertility Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Infertility Drugs Revenue Market Share by Type in 2019
1.2.3 Gonadotropins
1.2.4 Anti-Estrogens
1.3 Global Infertility Drugs Market by Application
1.3.1 Overview: Global Infertility Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Male
1.3.3 Female
1.4 Global Infertility Drugs Market by Regions
1.4.1 Global Infertility Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Infertility Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Infertility Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Infertility Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infertility Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Infertility Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infertility Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Infertility Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 LIVZON
2.2.1 LIVZON Details
2.2.2 LIVZON Major Business
2.2.3 LIVZON SWOT Analysis
2.2.4 LIVZON Product and Services
2.2.5 LIVZON Infertility Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ferring
2.3.1 Ferring Details
2.3.2 Ferring Major Business
2.3.3 Ferring SWOT Analysis
2.3.4 Ferring Product and Services
2.3.5 Ferring Infertility Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 MSD
2.4.1 MSD Details
2.4.2 MSD Major Business
2.4.3 MSD SWOT Analysis
2.4.4 MSD Product and Services
2.4.5 MSD Infertility Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bayer Zydus Pharma
2.5.1 Bayer Zydus Pharma Details
2.5.2 Bayer Zydus Pharma Major Business
2.5.3 Bayer Zydus Pharma SWOT Analysis
2.5.4 Bayer Zydus Pharma Product and Services
2.5.5 Bayer Zydus Pharma Infertility Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Product and Services
2.6.4 Abbott Infertility Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Infertility Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Infertility Drugs Players Market Share
3.2.2 Top 10 Infertility Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Infertility Drugs Revenue and Market Share by Regions
4.2 North America Infertility Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Infertility Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Infertility Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Infertility Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Infertility Drugs Revenue and Growth Rate (2015-2020)
5 North America Infertility Drugs Revenue by Countries
5.1 North America Infertility Drugs Revenue by Countries (2015-2020)
5.2 USA Infertility Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Infertility Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Infertility Drugs Revenue and Growth Rate (2015-2020)
6 Europe Infertility Drugs Revenue by Countries
6.1 Europe Infertility Drugs Revenue by Countries (2015-2020)
6.2 Germany Infertility Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Infertility Drugs Revenue and Growth Rate (2015-2020)
6.4 France Infertility Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Infertility Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Infertility Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Infertility Drugs Revenue by Countries
7.1 Asia-Pacific Infertility Drugs Revenue by Countries (2015-2020)
7.2 China Infertility Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Infertility Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Infertility Drugs Revenue and Growth Rate (2015-2020)
7.5 India Infertility Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Infertility Drugs Revenue and Growth Rate (2015-2020)
8 South America Infertility Drugs Revenue by Countries
8.1 South America Infertility Drugs Revenue by Countries (2015-2020)
8.2 Brazil Infertility Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Infertility Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Infertility Drugs by Countries
9.1 Middle East & Africa Infertility Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Infertility Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Infertility Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Infertility Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Infertility Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Infertility Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Infertility Drugs Market Forecast by Type (2019-2024)
10.3 Gonadotropins Revenue Growth Rate (2015-2025)
10.4 Anti-Estrogens Revenue Growth Rate (2015-2025)
11 Global Infertility Drugs Market Segment by Application
11.1 Global Infertility Drugs Revenue Market Share by Application (2015-2020)
11.2 Infertility Drugs Market Forecast by Application (2019-2024)
11.3 Male Revenue Growth (2015-2020)
11.4 Female Revenue Growth (2015-2020)
12 Global Infertility Drugs Market Size Forecast (2021-2025)
12.1 Global Infertility Drugs Market Size Forecast (2021-2025)
12.2 Global Infertility Drugs Market Forecast by Regions (2021-2025)
12.3 North America Infertility Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Infertility Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Infertility Drugs Revenue Market Forecast (2021-2025)
12.6 South America Infertility Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Infertility Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Infertility Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Infertility Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Infertility Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Infertility Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Infertility Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Merck Corporate Information, Location and Competitors
Table 7. Merck Infertility Drugs Major Business
Table 8. Merck Infertility Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Merck SWOT Analysis
Table 10. Merck Infertility Drugs Product and Solutions
Table 11. Merck Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. LIVZON Corporate Information, Location and Competitors
Table 13. LIVZON Infertility Drugs Major Business
Table 14. LIVZON Infertility Drugs Total Revenue (USD Million) (2018-2019)
Table 15. LIVZON SWOT Analysis
Table 16. LIVZON Infertility Drugs Product and Solutions
Table 17. LIVZON Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Ferring Corporate Information, Location and Competitors
Table 19. Ferring Infertility Drugs Major Business
Table 20. Ferring Infertility Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Ferring SWOT Analysis
Table 22. Ferring Infertility Drugs Product and Solutions
Table 23. Ferring Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. MSD Corporate Information, Location and Competitors
Table 25. MSD Infertility Drugs Major Business
Table 26. MSD Infertility Drugs Total Revenue (USD Million) (2017-2018)
Table 27. MSD SWOT Analysis
Table 28. MSD Infertility Drugs Product and Solutions
Table 29. MSD Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Bayer Zydus Pharma Corporate Information, Location and Competitors
Table 31. Bayer Zydus Pharma Infertility Drugs Major Business
Table 32. Bayer Zydus Pharma Infertility Drugs Total Revenue (USD Million) (2017-2018)
Table 33. Bayer Zydus Pharma SWOT Analysis
Table 34. Bayer Zydus Pharma Infertility Drugs Product and Solutions
Table 35. Bayer Zydus Pharma Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Abbott Corporate Information, Location and Competitors
Table 37. Abbott Infertility Drugs Major Business
Table 38. Abbott Infertility Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Abbott SWOT Analysis
Table 40. Abbott Infertility Drugs Product and Solutions
Table 41. Abbott Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Infertility Drugs Revenue (Million USD) by Players (2015-2020)
Table 43. Global Infertility Drugs Revenue Share by Players (2015-2020)
Table 44. Global Infertility Drugs Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Infertility Drugs Revenue Market Share by Regions (2015-2020)
Table 46. North America Infertility Drugs Revenue by Countries (2015-2020)
Table 47. North America Infertility Drugs Revenue Market Share by Countries (2015-2020)
Table 48. Europe Infertility Drugs Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Infertility Drugs Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Infertility Drugs Revenue by Countries (2015-2020)
Table 51. South America Infertility Drugs Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Infertility Drugs Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Infertility Drugs Revenue Market Share by Countries (2015-2020)
Table 54. Global Infertility Drugs Revenue (Million USD) by Type (2015-2020)
Table 55. Global Infertility Drugs Revenue Share by Type (2015-2020)
Table 56. Global Infertility Drugs Revenue Forecast by Type (2021-2025)
Table 57. Global Infertility Drugs Revenue by Application (2015-2020)
Table 58. Global Infertility Drugs Revenue Share by Application (2015-2020)
Table 59. Global Infertility Drugs Revenue Forecast by Application (2021-2025)
Table 60. Global Infertility Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Infertility Drugs Picture
Figure 2. Global Infertility Drugs Revenue Market Share by Type in 2019
Figure 3. Gonadotropins Picture
Figure 4. Anti-Estrogens Picture
Figure 5. Infertility Drugs Revenue Market Share by Application in 2019
Figure 6. Male Picture
Figure 7. Female Picture
Figure 8. Global Infertility Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Infertility Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Infertility Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Infertility Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Infertility Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Infertility Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Infertility Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Infertility Drugs Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Infertility Drugs Revenue Market Share in 2019
Figure 17. Global Top 10 Players Infertility Drugs Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Infertility Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Infertility Drugs Revenue Market Share by Regions (2015-2020)
Figure 21. Global Infertility Drugs Revenue Market Share by Regions in 2018
Figure 22. North America Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 23. Europe Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 25. South America Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 27. North America Infertility Drugs Revenue Market Share by Countries (2015-2020)
Figure 28. North America Infertility Drugs Revenue Market Share by Countries in 2019
Figure 29. USA Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Canada Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Europe Infertility Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Infertility Drugs Revenue Market Share by Countries in 2019
Figure 34. Germany Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 35. UK Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 36. France Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Russia Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Italy Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Infertility Drugs Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Infertility Drugs Revenue Market Share by Countries in 2019
Figure 41. China Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Japan Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Korea Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 44. India Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 46. South America Infertility Drugs Revenue Market Share by Countries (2015-2020)
Figure 47. South America Infertility Drugs Revenue Market Share by Countries in 2019
Figure 48. Brazil Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Infertility Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Infertility Drugs Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 53. UAE Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Infertility Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Global Infertility Drugs Revenue Share by Type (2015-2020)
Figure 57. Global Infertility Drugs Revenue Share by Type in 2019
Figure 58. Global Infertility Drugs Market Share Forecast by Type (2021-2025)
Figure 59. Global Gonadotropins Revenue Growth Rate (2015-2020)
Figure 60. Global Anti-Estrogens Revenue Growth Rate (2015-2020)
Figure 61. Global Infertility Drugs Revenue Share by Application (2015-2020)
Figure 62. Global Infertility Drugs Revenue Share by Application in 2019
Figure 63. Global Infertility Drugs Market Share Forecast by Application (2021-2025)
Figure 64. Global Male Revenue Growth Rate (2015-2020)
Figure 65. Global Female Revenue Growth Rate (2015-2020)
Figure 66. Global Infertility Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Infertility Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Infertility Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Infertility Drugs Revenue Market Forecast (2021-2025)
Figure 70. Europe Infertility Drugs Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Infertility Drugs Revenue Market Forecast (2021-2025)
Figure 72. South America Infertility Drugs Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Infertility Drugs Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
男性不妊症の世界市場（～2026年） Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing …- 男性不妊症診断・治療の世界市場（～2026年） Male infertility refers to a male's inability to cause pregnancy in a fertile female. The major factors that are augmenting the growth of the market are estimated to be increasing alcohol consumption, increasing age, rising environmental pollution etc. Additionally, increasing stress, changing life …
- 女性用不妊症診断・治療の世界市場（～2026年） Female infertility refers to infertility in female humans. The major factors that are augmenting the growth of the female infertility market are changing life style and increasing IVF market. Furthermore, rising trend of surrogacy, growing infertility rate among female, new technologies to avoid mul…
- 不妊治療の世界市場（～2026年） Market Analysis and Insights: Global Infertility Treatment Market The global Infertility Treatment market size is projected to reach US$ 1458 million by 2026, from US$ 1364.8 million in 2020, at a CAGR of 6.3%% during 2021-2026. Global Infertility Treatment Scope and Market Size Infertility Treatmen…
- 不妊症診断の世界市場（～2026年） Fertility diagnosis is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are p…